| 前收市價 | 0.1900 |
| 開市 | 0.1700 |
| 買盤 | 0.1600 |
| 賣出價 | 0.2200 |
| 拍板 | 20.00 |
| 到期日 | 2025-01-17 |
| 今日波幅 | 0.1700 - 0.1900 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 16.51k |
ZacksModerna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Data from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared with its previously approved bivalent COVID-19 vaccine.
ZacksPharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
An FDA panel endorses Eli Lilly's (LLY) Alzheimer's disease drug, donanemab. Pfizer's (PFE) DMD study on investigational gene therapy fails.
